Zur Pathobiochemie und Pathophysiologie reaktiver Oxidantien bei Ischämie und Reperfusion

Th. W. Stief

doi:10.1055/s-0038-1655269

Hämostaseologie, Table of Contents

Hamostaseologie 1989; 09(04): 190-198
DOI: 10.1055/s-0038-1655269

Originalarbeiten

Schattauer GmbH

Zur Pathobiochemie und Pathophysiologie reaktiver Oxidantien bei Ischämie und Reperfusion^[*]

Th. W. Stief

¹Abteilung für Hämatologie, Universitäts-Hospital »Virgen del Rocio«, Universität Sevilla (Spanien)

› Author Affiliations

Abstract

Zusammenfassung

Die Letalität des Myokardinfarkts ist heute durch rechtzeitige Verabreichung von Thrombolytika vom Typ der Plasminogenaktivatoren oder Durchführung einer Koronarangioplastie zurückgegangen. Bei der thromboly tischen Behandlung akuter thrombotischer Ereignisse wird allerdings auch der Oxidansphysiologie Rechnung getragen werden müssen, um durch den Einsatz hierauf zielender Therapeutika den Reperfusionsschaden am Gewebe weiter zu begrenzen.

Zur Vermeidung von ReperfusionsSchäden wird zukünftig eine effiziente Fibrinolysetherapie wahrscheinlich eine antientzündliche Begleitkomponente beinhalten. Substanzen mit bislang vermeintlich klarem klinischen Wirkungsprofil, wie Azetylsalizylsäure, Dipyridamol, Captopril, Heparin oder Kalziumantagonisten, könnten durchaus auf diese Weise ihren Teil zur therapeutischen Wirkung bei Ischämie/Reperfusion beitragen.

Full Text

References

LITERATUR
1 Abrams W R, Weinbaum G, Weissbach L, Weissbach H, Brot N. Enzymatic reduction of oxidized á₁-proteinase inhibitor restores biological activity. Proc Natl Acad Sci USA 1981; 78: 7483-6.
2 Adams D A. Molecular interactions in macrophage activation. Immunology Today 1989; 10: 33-5.
3 Albrich J M, Gilbaugh J H, Callahan K B, Hurst J K. Effects of the putative neutrophil-generated toxin, hypochlorous acid, on membrane permeability and transport systems of Escherichia coli. J Clin Invest 1986; 78: 177-84.
4 Allen D G, Orchard C H. Myocardial contractil function during ischemia and hypoxia. Circ Res 1987; 60: 153-68.
5 Ambrosio G, Becker L C, Hutchins G M, Weisman H F, Weisfeldt M L. Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation 1986; 74: 1424-33.
6 Ambrosio G, Zweier J L, Jacobus W E, Weisfeldt M L, Flaherty J T. Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation 1987; 76: 906-15.
7 Armstead W M, Mirro R, Burija D W, Leffler C W. Postischemic generation of superoxide anion by newborn pig brain. Am J Physiol 1988; 255: H 401-3.
8 Arroyo C M, Kramer J H, Dickens B F, Weglicki W B. Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPO. FEBS Lett 1987; 221: 101-4.
9 Babior B M. Oxygen dependent microbial killing by phagocytes. N Engl J Med 1978; 298: 659-68.
10 Baker P J, Lint T F, McLeod B C, Behrends C L, Gewürz H. Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis by polyanions and polycations. J Immunol 1975; 114: 554-8.
11 Baker P J, Lint T F, Siegel J, Kies M W, Gewürz H. Potentiation of C56-initiated lysis by leukocyte cationic proteins, myelin basic proteins, and lysine rich histones. Immunology 1976; 30: 467-73.
12 Banda M J, Rice A G, Griffin G L, Senior R M. tti-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase. J Biol Chem 1988; 263: 4481-4.
13 Bednar M, Smith B, Pinto A, Mullane K A. Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ Res 1985; 57: 131-41.
14 Bonow R O, Lipson L C, Sheehan F H, Capurro N L, Isner J M, Roberts W C, Goldstein R E, Epstein S E. Lack of effect of aspirin on myocardial infarct size in the dog. Am J Cardiol 1981; 47: 258-64.
15 Braunwald E, Kloner R A. Myocardial reperfusion : a double edged sword. J Clin Invest 1985; 76: 1713-9.
16 Britigan B E, Cohen M S, Rosen G M. Hydroxyl radical formation in neutrophils. N Engl J Med 1988; 318: 858-9.
17 Brower M S, Harpel P C. Proteolytic cleavage and inactivation of alpha-2-plasmin inhibitor and Cl-inactivator by human polymorphonuclear leukocyte elastase. J Biol Chem 1982; 257: 9849-54.
18 Cadenas E. Oxidative stress and formation of excited species. In: Oxidative Stress. Sies H. (ed). London: Academic Press; 1985: 311-26.
19 Carpenter L J, Johnson K J, Kunkel R G, Roth R A. Phorbol myristate acetate produces injury to isolated rat lungs in the presence and absence of perfused neutrophils. Toxicol Appl Pharmacol 1987; 91: 22-32.
20 Cerutti P A. Prooxidant states and tumor promotion. Science 1985; 227: 375-81.
21 Chatelain P, Latour J G, Tran D, De Lorgeril M, Dupras G, Bourassa M. Neutrophil accumulation in experimentell myocardial infarcts : relation with extent of injury and effect of reperfusion. Circulation 1987; 75: 1083-90.
22 Chien K R, Han A, Sen A. Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Relationship to a phosphatidylcholine-deacylation-reacylation cycle and depletion of membrane phospholipids. Circ Res 1984; 54: 313-22.
23 Coker S J, Parratt J R, Ledingham I M, Zeitlin I J. Thromboxane and prostacyclin release from ischemic myocardium in relation to arrhythmias. Nature 1981; 291: 323-4.
24 Coleman P L, Barouski-Miller P A, Gelehrter T D. The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells : a cellular product which specifically inhibits plasminogen activator. J Biol Chem 1982; 257: 4260-4.
25 Crawford M H, Grover F L, Kolb W P, McMahan C A, O’Rourke R A, McManus L M, Pinckhard R N. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 1988; 78: 1449-58.
26 Cross C E, Halliwell B, Borish E T. Oxygen radicals and human disease. Ann Intern Med 1987; 107: 526-45.
27 Davies K J A. Protein damage and degradation by oxygen radicals. I General aspects. J Biol Chem 1987; 262: 9895-901.
28 Davies K J A, Delsignore M E, Lin S W. Protein damage and degradation by oxygen radicals II modification of amino acids. J Biol Chem 1987; 262: 9902-7.
29 Declerck P J, De Mol M, Alessi M C, Baudner S, Pâques E P, Preissner K T, Müller-Berghaus G, Collen D. Purification and characterization of a plasminogen-activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin) J Biol Chem 1988; 263: 15454-61.
30 Duniec Z, Robak J, Gryglewski R. Antioxidant properties of some chemicals vs. their influence on cyclooxygenase and lipoxygenase and lipoxidase activities. Biochem Pharmacol 1983; 32: 2283-6.
31 Engler R L, Covell J W. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ Res 1987; 61: 20-8.
32 Engler R L, Schmid-Schönbein G W, Pavelec R S. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983; 111: 98-111.
33 Färber N E, Pieper G M, Thomas J P, Gross G J. Beneficial effects of iloprost in the stunned canine myocardium. Circ Res 1988; 62: 204-15.
34 Finkel T H, Pabst M J, Suzuki H, Guthrie L A, Forehand J R, Phillips W A, Johnston Hr R B. Priming of neutrophils and macrophages for enhanced release of superoxide anion by the calcium ionophore ionomycin. J Biol Chem 1987; 262: 12589-96.
35 Fligiel S E G, Lee E C, McCoy J P, Johnson K J, Varani J. Protein degradation following treatment with hydrogen peroxide. Am J Pathol 1984; 115: 418-25.
36 Flynn P J, Becker W K, Vercellotti GJ, Weisdorf DJ, Craddock PR, Hammerschmidt DE, Lillehei RC, Jacob HS. Ibuprofen inhibits granulocyte responses to inflammatory mediators. Inflammation 1984; 08: 33-44.
37 Foote C S, Goyne T E, Lehrer R I. Assessment of chlorination by human neutrophils. Nature 1983; 301: 715-6.
38 Ganote C F, Kaltenbach J P. Oxygen induced enzyme release: early events and a proposed mechanism. J Mol Cell Cardiol 1979; 11: 389-406.
39 Garlick P B, Davies M J, Hearse D J, Slater H. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987; 61: 757-60.
40 Goldstein I M. Complement: biologically active products. In: Infammation: Basic Principles and Clinical Correlates. Gallin J I, Goldstein I M, Snyderman R. (eds). New York: Raven Press; 1988: 55-74.
41 Goldstein I M, Lind S, Hoffstein S, Weissmann G. Influence of local anesthetics upon human polymorphonuclear leukocyte function, in vitro reduction of lysosomal enzyme release and superoxide production. J Exp Med 1977; 146: 483-94.
42 Grau E, Moroz L A. Fibrinolytic activity of normal human blood monocytes. Thromb Res 1989; 53: 145-62.
43 Greenwald R A, Moy W W. Inhibiton of collagen gelation by action of the superoxide radical. Arthritis Rheum 1979; 22: 251-9.
44 Grisham M B, Jefferson M M, Thomas E L. Role of monochloramine in the oxidation of erythrocyte hemoglobin by stimulated neutrophils. J Biol Chem 1984; 259: 6757-65.
45 Grum C M, Ragsdale R A, Ketai L H, Shlafer M. Absence of xanthine oxidase or xanthine dehydrogenase in rabbit myocardium. Biochem Biophys Res Comm 1986; 141: 1104-8.
46 Haber F, Weiss J. The catalytic decomposition of hydrogen peroxide by iron salts. J Proc Roy Soc 1934; 147: 332-51.
47 Haglund U, Lundgren O. Intestinal ischemia and shock factors. Fed Proc 1978; 37: 2729-33.
48 Halliwell B, Gutteridge J M C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984; 219: 1-14.
49 Hamers M N, Roos D. Oxidative stress in human neutrophilic granulocytes: host defence and self-defence. In: Oxidative Stress. Sies H. (ed). London: Academic Press; 1985: 351-76.
50 Hammerman H, Kloner R A, Hale S, Schoen F J, Braunwald E. Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. Circulation 1983; 68: 446-55.
51 Hatherill J R, Till G O, Bruner L H, Ward P A. Thermal injury, intravascular hemolysis, and toxic oxygen products. J Clin Invest 1986; 78: 629-36.
52 Hess M L, Manson N H. Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox, and ischemia/reperfusion injury. J Mol Cell Cardiol 1984; 16: 969-85.
53 Hirata F, Corcoran B A, Venkatasubramanian K, Schiffmann E, Axelrod J. Chemoattractants stimulate degradation of methylated phospholipids and release of arachidonic acid in rabbit leukocytes. Proc Natl Acad Sci USA 1979; 76: 2640-3.
54 Hyslop P A, Hinshaw D B, Halsey W A. Mechanisms of oxidant mediated cell injury: the glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem 1988; 263: 1665-75.
55 Ruoslahti III C R E. Association of thrombin-antithrombin-III complex with vitronectin in serum. J Biol Chem 1985; 260: 15610-5.
56 ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among. 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; II: 349-60.
57 Iuliano L, Ghiselli A, Alessandri C, Bonavita M S, Violi F. Superoxide anion scavenging property of dipyridamol. Thromb Haemost 1989; 61: 149 (letter).
58 Jochum M, Lander S, Heimburger N, Fritz H. Effect of human granulocytic elastase on isolated human antithrombin III. Hoppe-Seyler’s Z Physiol Chemie 1981; 362: 103-12.
59 Johnson D, Travis J. The oxidative inactivation of human alpha-1-proteinase inhibitor. J Biol Chem 1979; 254: 4022-6.
60 Jolly S R, Kane W J, Bailie M B, Abrams G D, Lucchesi B R. Canine myocardial reperfusion injury: its reduction by the combined administration of superoxide dismutase and Catalase. Circ Res 1984; 54: 277-85.
61 Jones D P. The role of oxygen concentration in oxidative stress: hypoxic and hyperoxic models. In: Oxidative Stress. Sies H. (ed). London: Academic Press; 1985: 152-89.
62 Jordan R E, Kilpatrick J, Nelson R M. Heparin promotes the inactivation of antithrombin by neutrophil elastase. Science 1987; 238: 777-9.
63 Kanofsky J R, Hoogland H, Wever R, Weiss S J. Singlet oxygen production by human eosinophils. J Biol Chem 1988; 263: 9692-6.
64 Kinsman J M, Murry C E, Richard V J, Jennings R B, Reimer K A. The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion. J Am Coll Cardiol 1988; 12: 209-17.
65 Klein H H, Nebendahl, Schubote M, Kreuzer H. Intra-coronary hyperosmotic manitol during reperfusion does not affect infarct size in ischemic reperfused porcine hearts. Basic Res Cardiol 1985; 80: 251-9.
66 Kontos H A, Wei E P, Ellis E F, Jenkins L W, Povlishock J T, Rowe G T, Hess M L. Appearance of superoxide anion radical in cerebral extracellular space during prostaglandin synthesis in the cats. Circ Res 1985; 57: 142-51.
67 Koster J F, Slee R G. Ferritin: a physiological iron donor for microsomal lipid peroxidation. FEBS Lett 1986; 199: 85-8.
68 Kramer J H, Arroyo C M, Dickens B F, Weglicki W B. Spin-trapping evidence that graded myocardial ischemia alters postischemic superoxide production. Free Rad Biol Med 1987; 03: 153-9.
69 Lawrence D A, Loskutoff D J. Inactivation of plasminogen activator inhibitor by oxidants. Biochemistry 1986; 25: 6351-5.
70 Lehrer R I, Ganz T, Selsted M E, Babior B M, Curnutte J T. Neutrophils and host defense. Ann Intern Med 1988; 109: 127-42.
71 Libby P, Maroko P R, Bloor C M, Sobel B E, Braunwald E. Reduction of experimental myocardial infarct size by corticosteroid administration. J Clin Invest 1973; 52: 599-604.
72 Lijnen R, Holmes W E, van Hoef B, Wiman B, Rodriguez H, Collen D. Amino-acid sequence of human á₂-antiplasmin. Eur J Biochem 1987; 166: 565-74.
73 Lucchesi B R, Mullane K M. Leukocytes and ischemia induced myocardial injury. Ann Rev Pharmacol Toxicol 1986; 26: 201-7.
74 Lüscher E F. Activated leukocytes and the hemostatic system. Rev Infect Dis 1987; 09 (Suppl. 05) S 546-52.
75 Macartney H W, Tschesche H. Latent collagenase from human polymorphonuclear leukocytes and activation to collagenase by removal of an inhibitor. FEBS Lett 1980; 119: 327-32.
76 MacGregor R R, Thorner R E, Wright D M. Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites. Blood 1980; 56: 203-9.
77 Malech H L, Gallin J I. Neutrophils in human diseases. N Engl J Med 1987; 317: 687-94.
78 Manning A S. Reperfusion-induced arrhythmias: do free radicals play a critical role?. Free Radie Biol Med 1988; 04: 305-16.
79 Manning A S, Hearse D J. Reperfusioninduced arrhythmias : mechanisms and prevention. J Mol Cell Cardiol 1984; 16: 497-518.
80 Marx R. Hämostaseologie (Habil). München; 1953: 350-2.
81 Maza S R, Frishman W H. Therapeutic options to minimize free radical damage and thrombogenicity in ischemic/reperfused myocardium. Am Heart J 1987; 114: 1206-15.
82 McCord J M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-63.
83 McLeod B C, Baker P, Gewürz H. Studies on the inhibition of C56-initiated lysis (reactive lysis). II. C567-INH an inhibitor of the C567 trimolecular complex of complement. Int Arch Allergy 1974; 47: 623-32.
84 Meerson F Z, Kagan V E, Kazlov Y P, Belkina L M, Arkhipenko Y V. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxydant protection of the heart. Basic Res Cardiol 1982; 77: 465-85.
85 Mehta J L, Lopez L M, Lawson D, Wargovich T J, Williams L L. Dietary supplementation with omega-3 polyunsaturated fatty acids in patients with stable coronary heart disease. Effects on indices of platelet and neutrophil function and exercise performance. Am J Med 1988; 84: 45-52.
86 Mitsos S E, Askew T E, Fantone J C, Kunkel S L, Abrams G D, Schork A, Lucchesi B R. Protective effects of N-2mercapto-propionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular derived free radicals. Circulation 1986; 73: 1077-86.
87 Myers C L, Weiss S J, Kirsh M M, Shlafer M. Involvement of hydrogen peroxide and hydroxyl radical in the »oxygen paradox«: reduction of creatine kinase release by catalase, allopurinol or deferoxamine, but not by superoxide dismutase. J Mol Cell Cardiol 1985; 17: 675-84.
88 Müller-Berghaus G. Septicemia and the vessel wall. In: Thrombosis and Haemostasis 1987. Verstraete M, Vermylen J, Lijnen R, Arnout J. (eds). Leuven: Leuven University Press; 1987: 619-71.
89 Mullane K M, Read N, Salmon J A, Moncada S. Role of leukocytes in acute myocardial infarction in anesthesized dogs: relationship to myocardial salvage by antiinflammatory drugs. J Pharmacol Exp Ther 1984; 228: 510-22.
90 Mullane K M, Salmon J A, Kraemer R. Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury. Fed Proc 1987; 46: 2422-33.
91 Nathan C F. Secretory products of macrophages. J Clin Invest 1987; 79: 319-26.
92 Nayler W G, Elz V S. Reperfusion injury: laboratory artifact or clinical dilemma?. Circulation 1986; 74: 215-21.
93 Nejima J, Knight D R, Fallon J T, Uemura N, Manders W T, Canfield D R, Cohen MV, Vatner SF. Superoxide Dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation 1989; 79: 143-53.
94 O’Neill P G, Charlat M L, Kim H S, Pocius J, Michael L H, Hartley C J, Zhu W C, Roberts R, Bolli R. Lipoxygenase inhibitor nafazatrom fails to attenuate postischemic ventricular dysfunction. Cardiovasc Res 1987; 21: 755-60.
95 Peck S L, Johnston Jr R B, Horowitz L D. Reduced neutrophil superoxide anion release after prolonged infusions of lidocaine. J Pharmacol Exp Ther 1985; 235: 418-22.
96 Peppin G J, Weiss S J. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sei USA 1986; 83: 4322-6.
97 Petroski R J, Naccache P H, Becker E L, Sha’afi R I. Effect of the chemotactic factor formyl-methionyl-leucyl-phenylalanine and cytochalasin B on the cellular levels of calcium in rabbit neutrophils. FEBS Lett 1979; 100: 161-5.
98 Pinckard R N, O’Rourke R A, Crawford M H, Grover F S, McManus L M, Ghidoni J J, Storrs S B, Olson M S. Complement localization and mediation of ischemic injury in baboon myocardium. J Clin Invest 1980; 66: 1050-6.
99 Plow E F. The contribution of leukocyte proteases to fibrinolysis. Blut 1986; 53: 1-9.
100 Plow E F, Plescia J. Neutrophil secretion during blood coagulation: evidence for a prekallikrein independent pathway. Thromb Haemost 1988; 59: 360-3.
101 Podack C J, Müller-Eberhard H J. Isolation of human S-protein of complement, an inhibitor of the membrane attack complex of complement. J Biol Chem 1979; 254: 9908-14.
102 Preissner K T. S-Protein (Vitronektin): Die Rolle des multifunktionellen Adhäsivproteins im Gerinnungsund Komplementsystem an der Interphase Blut-Gefäßwand. Hämostaseologie 1988; 08: 183-97.
103 Rao P S, Mueller H S. Lipid peroxidation and acute myocardial ischemia. Adv Exp Med Biol 1983; 161: 347-63.
104 Reimer K A, Jennings R B. Failor of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs. Circulation 1985; 71: 1069-75.
105 Richard V J, Murry C E, Jennings R B, Reimer K A. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs. Circulation 1988; 78: 473-80.
106 Romson J L, Hook B G, Kundel S L, Abrams G D, Schork M A, Lucchesi B R. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Am J Cardiol 1981; 47: 258-64.
107 Rossen R D, Swain J S, Michael L H, Weakley S, Giannini E, Entman M L. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury. Circ Res 1985; 57: 119-30.
108 Roy R S, McCord J M. Superoxide and ischemia: conversion of xanthine dehydrogenase to xanthine oxidase. In: Oxygen Radicals and their Scavenger Systems. Vol. 2. Cellular and Molecular Aspects. Greenwald R, Cohen G. (eds). New York: Elsevier Science; 1983: 145-53.
109 Ruf W, McNamara J J, Suchiro A, Cuchiro G, Wickline S A. Platelet trapping in myocardial infarct in baboons: therapeutic effect of aspirin. Am J Cardiol 1980; 46: 405-12.
110 Schafer H, Mathey D, Hugo F, Bhakdi S. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol 1986; 137: 1945-9.
111 Schmid-Schönbein G W. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 1987; 46: 2397-401.
112 Schraufstatter I U, Revak SD, Cochrane CG. Proteases and oxidants in experimental pulmonary inflammatory injury. J Clin Invest 1984; 73: 1175-84.
113 Seifert S C, Gelehrter T D. Mechanism of glucocorticoid inhibition of plasminogen activator in rat hepatoma cells. Proc Natl Acad Sci USA 1978; 75: 6130-3.
114 Shechter Y, Burstein Y, Patchornik A. Selective oxidation of methionine residues in proteins. Biochem 1975; 14: 4497-503.
115 Shieh B H, Travis J. The reactive site of human alpha-2-antiplasmin. J Biol Chem 1987; 262: 6055-9.
116 Smith M T, Evans C G, Thor H, Orrenius S. Quinone-induced oxidative injury to cells and tissues. In: Oxidative Stress. Sies H. (ed). London: Academic Press; 1985: 91-110.
117 Smolen J E, Korchak H M, Weissmann G. Stimulation increases levels of cyclic adenosine 3’,5’-monophosphate in human polymorphonuclear leukocytes exposed to surface stimuli. J Clin Invest 1980; 65: 1077-85.
118 Stief T W. Functional determination of scu-PA in human plasma using selective oxidants. ETRO Working Party on Fibrinolysis. Leiden 1988; 1.
119 Stief T W, Aab A, Heimburger N. Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III and Cl-inhibitor. Thromb Res 1988; 49: 581-9.
120 Stief T W, Heimburger N. Inactivation of serine protease inhibitors (serpins) in human plasma by reactive oxidants. Biol Chem Hoppe-Seyler 1988; 369: 1337-42.
121 Stief T W, Lenz P, Becker U, Heimburger N. Determination of plasminogen activator inhibitor (PAI) capacity of human plasma in presence of oxidants: a novel principle. Thromb Res 1988; 50: 559-73.
122 Stief T W, Marx R, Heimburger N. Oxidized fibrin(ogen) derivatives enhance the activity of tissue type plasminogen activator. Thromb Res. 1989 (in press)
123 Stief T W, Radtke K P, Heimburger N. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3. Biol Chem Hoppe-Seyler 1987; 368: 1427-33.
124 Tappy L, Hauert F, Bachmann F. Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system. Thromb Res 1984; 33: 117-24.
125 Test S T, Weiss S J. Quantitative and temporal characterization of the extracellular H₂0₂ pool generated by human neutrophils. J Biol Chem 1984; 259: 399-405.
126 Thomas E L, Grisham M B, Jefferson M M. Myeloperoxidase-dependent effect of amines on functions of isolated neutrophils. J Clin Invest 1983; 72: 441-54.
127 Tomasini B R, Mosher D F. On the identity of vitronectin and S-protein; immunological crossreactivity and functional studies. Blood 1986; 68: 737-42.
128 Travis J, Salvesen G S. Human plasma proteinase inhibitors. Ann Rev Biochem 1983; 52: 655-709.
129 Uraizee A, Reimer K A, Murry C E, Jennings R B. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation 1987; 75: 1237-48.
130 Vander Heide R S, Sobotka P A, Ganote C E. Effects of the free radical scavenger DMTU and mannitol on the oxygen paradox in perfused rat hearts. J Mol Cell Cardiol 1987; 19: 615-85.
131 van der Kraaij A M M, Mostert L J, van Eijk H G, Koster J F. Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+) cyanidanol-3 and deferoxamine. Circulation 1988; 78: 442-9.
132 Vatner S F, Patrick T A, Knight D R, Manders W T, Fallon J T. Effects of calcium channel blocker on responses of blood flow, function, arrhythmias, and extent of infarction following reperfusion in conscious baboons. Circ Res 1988; 62: 105-15.
133 Ward P A, Till G O, Kunkel R, Beauchamp C. Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury. J Clin Invest 1983; 72: 789-801.
134 Wasil M, Halliwell B, Hutchison D C, Baum H. The antioxidant action of human extracellular fluids : effect of human serum and its protein components on the inactivation of alpha-l-antiproteinase by hypochlorous acid and by hydrogen peroxide. Biochem J 1987; 243: 219-23.
135 Weiss S J. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
136 Weiss S J, Lampert M B, Test S T. Longlived oxidants generated by human neutrophils: characterization and bioactivity. Science 1983; 222: 625-8.
137 Weiss S J, Regiani S. Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor: cooperative use of lysosomal proteinases and oxygen metabolites. J Clin Invest 1984; 73: 1297-303.
138 Westlin W, Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavinging free radicals?. Circulation 1988; 77: 130-9.
139 Wiman B, Boman L, Collen D. On the kinetics of the reaction between human antiplasmin arid a low-molecular-weight form of plasmin. Eur J Biochem 1978; 87: 143-6.
140 Zimmerman A N E, Hulsmann W C. Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 1966; 211: 646-7.
141 Zimpfer M, Manders W T, Barger A C, Vatner S E. Pentobarbital alters compensatory neural and humoral mechanisms in response to hemorrhage. Am J Physiol 1982; 243: H 713-21.
142 Zurier R B, Weissmann G, Hoffstein S, Kammermann S, Tai H H. Mechanisms of lysosomal enzyme release from human leukocytes. J Clin Invest 1974; 53: 297-309.
143 Zweier J L. Measurement of superoxidederived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J Biol Chem 1988; 263: 1353-7.
144 Zweier J L, Flaherty J T, Weisfeldt M L. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Nat Acad Sei USA 1987; 84: 757-62.

Zur Pathobiochemie und Pathophysiologie reaktiver Oxidantien bei Ischämie und Reperfusion[*]

Zur Pathobiochemie und Pathophysiologie reaktiver Oxidantien bei Ischämie und Reperfusion^[*]